Cochrane Abstracts
PEG‐asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PEG‐asparaginase Treatment regimens for Acute Lymphoblastic Leukaemia in Children: a Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431359/all/PEG‐asparaginase_treatment regimens_for_acute_lymphoblastic_leukaemia_in_children:_a_network_meta‐analysis.
PEG‐asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431359/all/PEG‐asparaginase_treatment regimens_for_acute_lymphoblastic_leukaemia_in_children:_a_network_meta‐analysis. Accessed January 15, 2025.
PEG‐asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta‐analysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431359/all/PEG‐asparaginase_treatment regimens_for_acute_lymphoblastic_leukaemia_in_children:_a_network_meta‐analysis
PEG‐asparaginase Treatment regimens for Acute Lymphoblastic Leukaemia in Children: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431359/all/PEG‐asparaginase_treatment regimens_for_acute_lymphoblastic_leukaemia_in_children:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PEG‐asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta‐analysis
ID - 431359
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431359/all/PEG‐asparaginase_treatment regimens_for_acute_lymphoblastic_leukaemia_in_children:_a_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
